EE362 A Budget Impact Analysis of Pertuzumab, Trastuzumab, and Chemotherapy in the Neoadjuvant Setting for HER2-Positive High-Risk Early Breast Cancer Patients: Insights from the Tuscany Regional Health Care System Perspective
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.628
https://www.valueinhealthjournal.com/article/S1098-3015(23)03758-0/fulltext
Title :
EE362 A Budget Impact Analysis of Pertuzumab, Trastuzumab, and Chemotherapy in the Neoadjuvant Setting for HER2-Positive High-Risk Early Breast Cancer Patients: Insights from the Tuscany Regional Health Care System Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03758-0&doi=10.1016/j.jval.2023.09.628
First page :
Section Title :
Open access? :
No
Section Order :
10119